戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 d, as well as blood entering and exiting the dialyzer.
2 ll tolerated and reduced clotting within the dialyzer.
3 e of dialysis and to a low-flux or high-flux dialyzer.
4  and 5th, 10th, 15th, and 20th reuse of each dialyzer.
5 atments with a single T220L dialyzer or F80B dialyzer.
6 n hospital-based facilities not reprocessing dialyzers.
7 among hospital-based facilities reprocessing dialyzers.
8  in freestanding facilities not reprocessing dialyzers.
9 ith new or reprocessed high-flux polysulfone dialyzers.
10 lysulfone dialyzers but not with polynephron dialyzers.
11 single use) or reprocessed (reuse) cellulose dialyzers.
12 tent with less blood accumulation within the dialyzers.
13 n dialyzers and were switched to polysulfone dialyzers.
14 e not reduced by higher dose or by high flux dialyzers.
15 was undetectable in the dialysate with T220L dialyzers.
16 inical dialysis, especially with reprocessed dialyzers.
17 cellulose-tri-acetate (CTA), and polysulfone dialyzers.
18 (P < 0.05) than that observed with cellulose dialyzers.
19 tically significant (P < 0.05) for all three dialyzers.
20 s dialyzed with new or reprocessed cellulose dialyzers.
21 ymptomatic hypotension in patients on reused dialyzers (11 +/- 3) compared with patients on single-us
22 e dialyzers and were switched to polynephron dialyzers; 41 patients started on polynephron dialyzers
23 ions over 10 days) with either a high-cutoff dialyzer (46 patients) or a conventional high-flux dialy
24 er (46 patients) or a conventional high-flux dialyzer (48 patients).
25  +/- 3) compared with patients on single-use dialyzers (8 +/- 2).
26 taraldehyde and bleach-reprocessed cellulose dialyzers after random assignment to 12 wk of dialysis w
27                                    With F80B dialyzers, albumin was detected in the dialysate in four
28 e exposed to 11.5-year-old cellulose acetate dialyzers (all of these dialyzers were discarded by the
29 tended hemodialysis with the Gambro HCO 1100 dialyzer allowed continuous, safe removal of FLC in larg
30 osure to aged cellulose acetate membranes of dialyzers, allowing cellulose acetate degradation produc
31 ly, with reuse, creatinine clearance of F80B dialyzers also decreased at Qb 300 (P = 0.07) and Qb 400
32 tain the required parts, (ii) assembling the dialyzer and (iii) sealing the dialyzer with epoxy.
33  were no significant differences between new dialyzers and dialyzers reprocessed once.
34 eek hemodialysis to either high- or low-flux dialyzers and either ultrapure or standard dialysate usi
35 dialysis: 28 patients started on polysulfone dialyzers and were switched to polynephron dialyzers; 41
36 ialyzers; 41 patients started on polynephron dialyzers and were switched to polysulfone dialyzers.
37 tively, with cellulose, CTA, and polysulfone dialyzers, and postdialysis levels were 17,834 +/- 861,
38 ignificantly different from that of new F80B dialyzers at either Qb.
39                       Urea clearance of F80B dialyzers at Qb 300 decreased from 241 +/- 2 ml/min for
40 ve predialysis serum beta(2)M levels but not dialyzer beta(2)M clearance were associated with all-cau
41  baseline residual kidney urea clearance and dialyzer beta(2)M clearance were strong predictors of pr
42 the associations of serum beta(2)M levels or dialyzer beta(2)M clearance with mortality.
43                               In conclusion, dialyzer BPA content may contribute to BPA burden in pat
44 er one hemodialysis session with polysulfone dialyzers but not with polynephron dialyzers.
45 n clearance of F80B was < 5.0 ml/min for new dialyzers, but increased to 21.2 +/- 5.3 ml/min (Qb 300)
46  clearance or by binding to materials in the dialyzer circuit.
47 ex) is either bound or removed from blood by dialyzer circuits.
48 ficant removal of the drug from the blood by dialyzer clearance or by binding to materials in the dia
49 mphasize the greater need for information on dialyzer clearances during clinical dialysis, especially
50                                              Dialyzer clotting can lead to anemia despite erythropoie
51 reduced potassium and iron entrapment in the dialyzers, consistent with less blood accumulation withi
52 20, and 225 +/- 32 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers rep
53 11, and 270 +/- 35 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers rep
54 35, and 427 +/- 67 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers rep
55  0, and 213 +/- 22 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers rep
56 trast, urea or creatinine clearance of T220L dialyzers did not decrease with reuse at either Qb.
57         Chronic (3-month) use of polysulfone dialyzers did not significantly increase predialysis ser
58  from Amicon-20 Diafilters or Fresenius F-80 dialyzers during continuous venovenous hemofiltration (C
59 mpliance, vascular access recirculation, and dialyzer dysfunction.
60            The study utilized five different dialyzers, each with a widely varying membrane type, and
61 ot significantly different between the three dialyzers either predialysis (P = 0.28) or postdialysis
62                                          The dialyzers evaluated contained either modified cellulosic
63                       We previously used the dialyzer for small-volume non-enzymatic RNA synthesis re
64  after chronic hemodialysis with polysulfone dialyzers (from 0.039+/-0.002 to 0.043+/-0.001 ng/10(6)
65 lls, P<0.01), but decreased with polynephron dialyzers (from 0.045+/-0.001 to 0.036+/-0.001 ng/10(6)
66                Hemodialysis with reprocessed dialyzers has been associated with an increased mortalit
67  in the United States, performance of reused dialyzers has not been extensively and critically evalua
68  reprocessed high-efficiency and "high-flux" dialyzers has raised concerns about the increased risk o
69 rmore, chronic hemodialysis with polysulfone dialyzers increased oxidative stress in PBMCs and inflam
70                                          Pre-dialyzer infusion of PBUT binding competitors into the b
71                                 The liposome dialyzer is a small-volume equilibrium dialysis device,
72                                          The dialyzer is prepared by modification of commercially ava
73                                          The dialyzer is prepared in three stages: (i) disassembling
74  Because adsorptive capacity of hollow-fiber dialyzers is limited, we sought to determine whether hem
75 ong the several disadvantages of reprocessed dialyzers is the concern that reuse could decrease the c
76 nd test solute is improved by increasing the dialyzer mass transfer area coefficient (KoA) and the di
77 ystem 3 hemodialysis machine; Fresenius F80B dialyzer; median blood flow rate 400 ml/min; dialysate f
78 ose of dialysis and the level of flux of the dialyzer membrane on mortality and morbidity among patie
79         In this study, surfaces of polymeric dialyzer membranes, consisting of polysulfone (PS) and p
80 tocrit monitoring and improved biocompatible dialyzer membranes.
81  toxins and decreases their diffusion across dialyzer membranes.
82 (1) a three-compartment patient model, (2) a dialyzer model.
83 an arterial/venous tube segment model, and a dialyzer model.
84 ation of field-retrieved 0- to 13.6-year-old dialyzers of similar type indicated significant chemical
85 ntaining polysulfone or BPA-free polynephron dialyzers on BPA levels in 69 prevalent patients on hemo
86 o 21 dialysis treatments with a single T220L dialyzer or F80B dialyzer.
87 ircuit with either new high-flux polysulfone dialyzers or dialyzers reprocessed once or 20 times with
88 in free-standing facilities not reprocessing dialyzers or in those reprocessing with formaldehyde.
89 igher than predialysis levels with all three dialyzers (P < 0.05).
90 were statistically significant for all three dialyzers (P < 0.05).
91  in predialysis BPI levels between the three dialyzers (P = 0.21).
92                 A more accurate knowledge of dialyzer performance in vivo would help to ensure that t
93                                With improved dialyzer performance, removal of strongly bound PBUTs im
94 od line tubing directly or indirectly during dialyzer priming and tubing assembly.
95 han treatment in facilities not reprocessing dialyzers (rate ratio [RR],1.10, 95% confidence interval
96                   Chronic use of polynephron dialyzers reduced predialysis serum BPA (from 70.6+/-8.4
97 w dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20 times (P = 0.004).
98 w dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20 times (P = 0.006).
99 w dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20 times (P = 0.008).
100 w dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20 times (P = 0.20).
101           IL-1 alpha production by PBMC from dialyzers reprocessed 20 times was significantly greater
102 ither new high-flux polysulfone dialyzers or dialyzers reprocessed once or 20 times with formaldehyde
103  +/- 32 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20
104  +/- 35 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20
105  +/- 67 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20
106  +/- 22 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20
107  was significantly greater than both new and dialyzers reprocessed once.
108 ficant differences between new dialyzers and dialyzers reprocessed once.
109 e (T220L) and "high-flux" polysulfone (F80B) dialyzers reprocessed with formaldehyde and bleach.
110 (beta2M) clearance by low-flux and high-flux dialyzers reprocessed with various germicides.
111 /- 2% and 65 +/- 2% for reuse and single-use dialyzers, respectively (not significant).
112 /- 1151% for cellulose, CTA, and polysulfone dialyzers, respectively.
113 s ratios for cellulose, CTA, and polysulfone dialyzers, respectively.
114 ialysis with cellulose, CTA, and polysulfone dialyzers results in a significant increase in LBP and B
115                                     Although dialyzer reuse in chronic hemodialysis patients is commo
116   During the 12-wk study, the mean number of dialyzer reuses was 7 +/- 1 in the reuse group and there
117 s and the effects of dialysate flow rate and dialyzer size on PBUT removal.
118 rd higher HD doses and use of more high-flux dialyzers, suggest the need to redetermine the dose leve
119 emodialysis was performed with a custom-made dialyzer (surface area 150 cm2) against a bicarbonate-bu
120                           Preparation of the dialyzer takes approximately 1.5 h, not including overni
121                                         This dialyzer then was evaluated in eight patients with myelo
122  300 decreased from 241 +/- 2 ml/min for new dialyzers to 221 +/- 5 ml/min after 20 reuses (P < 0.001
123 1), and Qb 400 from 280 +/- 4 ml/min for new dialyzers to 253 +/- 7 ml/min after 20 reuses (P = 0.001
124 a conventional hemodialysis device bearing a dialyzer, two pumps and connecting tubes, to build a rou
125   Among freestanding facilities reprocessing dialyzers, use of peracetic/acetic acid was associated w
126 earance of PPi by a 2.1-m2 cellulose acetate dialyzer was 36%, and the mean PPi removal in five patie
127 o studies indicated that the Gambro HCO 1100 dialyzer was the most efficient of seven tested.
128 extended hemodialysis with a protein-leaking dialyzer was used.
129      Beta 2 microglobulin clearance of T220L dialyzers was < 5.0 ml/min across the reuses studied.
130    Urea or creatinine clearance of new T220L dialyzers was not significantly different from that of n
131                      Urea clearance of T220L dialyzers was significantly higher than that of F80B at
132 ld cellulose acetate dialyzers (all of these dialyzers were discarded by the hospital before our inve
133  and hospital-based units that did not reuse dialyzers were not significantly different from each oth
134 g/mL) and polysulfone (10.73 +/- 2.24 ng/mL) dialyzers were significantly greater (P < 0.05) than tha
135 r involves infusing a binding competitor pre-dialyzer, which competes with PBUTs for their albumin bi
136 ssembling the dialyzer and (iii) sealing the dialyzer with epoxy.
137 e that reprocessing of high-flux polysulfone dialyzers with bleach increases the risk of reverse-tran
138 ival in freestanding facilities reprocessing dialyzers with either formaldehyde (RR,1.03, 95% CI, 0.9
139 al in hospital-based facilities reprocessing dialyzers with either peracetic/acetic acid (RR=0.95, 95
140 s suggest that the reprocessing of cellulose dialyzers with glutaraldehyde and bleach does not affect
141 ysis in freestanding facilities reprocessing dialyzers with peracetic/acetic acid may be associated w
142 ysis in freestanding facilities reprocessing dialyzers with the combination of peracetic and acetic a
143 in light chains) or a conventional high-flux dialyzer (with small pores and lower permeability).
144 reated with hemodialysis using a high-cutoff dialyzer (with very large membrane pores and high permea

 
Page Top